市场调查报告书
商品编码
1006308

再生不良性贫血的全球市场:各治疗类型,各疾病类型,各给药途径,各流通管道,各地区的,市场规模调查与预测(2020年~2027年)

Global Aplastic Anemia Market Size study, by Treatment type, By disease type, Route of administration (Intravenous and oral), by Distribution channel and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

全球再生不良性贫血的市场规模在2020年~2027年间的预测期间内,预计将以健全的成长率增长。

再生障碍性贫血市场需求的主要驱动力是全球血液疾病病例数量的增加。然而,治疗费用是影响治疗选择的主要因素,高昂的治疗成本会阻碍再生障碍性贫血治疗市场的增长。

这份报告提供再生不良性贫血的世界市场调查,提供市场概要,市场成长要素及阻碍因素分析,市场机会,治疗类型·疾病类型·给药途径·流通管道·各地区的市场规模的变化与预测,竞争情形,主要企业的简介等系统性资讯。

目录

第1章 摘要整理

第2章 市场定义和范围

第3章 市场动态

  • 市场影响分析(2018年~2027年)

第4章 产业分析

  • 波特的五力分析
  • PEST分析
  • 投资采用模式
  • 分析师的推荐事项与结论

第5章 各治疗类型

  • 市场概述
  • 效能:潜在的分析
  • 市场规模预测:2017年~2027年(10亿美元单位)
  • 子区隔分析
    • 骨髓移植·干细胞治疗
    • 输血
    • 药物治疗

第6章 各疾病类型

  • 市场概述
  • 效能:潜在的分析
  • 市场规模预测:2017年~2027年(10亿美元单位)
  • 子区隔分析
    • 再生不良性贫血
    • 遗传性骨髓不全症候群

第7章 各给药途径

  • 市场概述
  • 效能:潜在的分析
  • 市场规模预测:2017年~2027年(10亿美元单位)
  • 子区隔分析
    • 静脉
    • 口服

第8章 各流通管道

  • 市场概述
  • 效能:潜在的分析
  • 市场规模预测:2017年~2027年(10亿美元单位)
  • 子区隔分析
    • 零售药局
    • 医院药局
    • 线上药局

第9章 各地区

  • 地区市场概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲的概述
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 亚太地区的概述
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地区

第10章 竞争资讯

  • 顶级市场策略
  • 企业简介
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Ligand Pharmaceuticals Incorporated
    • Genzyme Corporation
    • Mylan N.V.
    • Biogen
    • Otsuka Pharmaceutical Co. Ltd.
    • Regen BioPharma Inc.
    • BioLineRx

第11章 调查流程

目录

Global Aplastic Anemia Market is valued approximately USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2020-2027. Aplastic anemia is a condition that happens when your body stops generating sufficient new blood cells. The condition leaves you tired and more prone to uncontrolled bleeding and infections. Aplastic anemia, a rare and serious condition, may develop at any age. It can happen suddenly, or slowly and worsen over time. It can be either moderate or severe. Medications, blood transfusions or a stem cell transplant, also known as a bone marrow transplant, may be included in aplastic anemia treatment. Rising number of blood disorder cases across the world is the major factor stimulating the demand for aplastic anemia market. For instance, as per Statista, Hemophilia A and B and von Willebrand disease are the most prevalent types of bleeding disorders. There were around 210,454 individuals worldwide who were diagnosed with haemophilia in 2018 and 78,500 who were diagnosed with von Willebrand disease. Also, In 2018, it was estimated that more than 13,600 individuals were diagnosed with haemophilia A in the United States, while about 4,100 were diagnosed with haemophilia B. However, Treatment costs are a major factor influencing the choice of therapy. Bone marrow transplantation costs are over USD 300,000. Thus, high treatment costs are likely to hamper the growth of the market for aplastic anemia treatment.

The regional analysis of global Aplastic Anemia market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the high prevalence rate of blood disorder. Whereas Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2020-2027. Factors such as increase in awareness about aplastic anemia and blood disorders would create lucrative growth prospects for the Aplastic Anemia market across Asia-Pacific region.

Major market player included in this report are:

Bayer AG

Novartis AG

Pfizer Inc.

Ligand Pharmaceuticals Incorporated

Genzyme Corporation

Mylan N.V.

Biogen

Otsuka Pharmaceutical Co. Ltd.

Regen BioPharma Inc.

BioLineRx

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Bone Marrow Transfusion/stem cell therapy

Blood Transfusion

Drug Therapy

By Diseases Type:

Acquired aplastic anemia

Inherited bone marrow failure syndromes

By Route of administration:

Intravenous

Oral

By Distribution channel:

Retail pharmacies

Hospital pharmacies

Online pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Aplastic Anemia Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Aplastic anemia Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Aplastic anemia Market, by Treatment type, 2018-2027 (USD Billion)
    • 1.2.3. Aplastic anemia Market, by Diseases type, 2018-2027 (USD Billion)
    • 1.2.4. Aplastic anemia Market, by Route of administration, 2018-2027 (USD Billion)
    • 1.2.5. Aplastic anemia Market, by Distribution channel, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Aplastic anemia Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Aplastic anemia Market Dynamics

  • 3.1. Aplastic anemia Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Aplastic anemia Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Aplastic anemia Market, by Treatment type

  • 5.1. Market Snapshot
  • 5.2. Global Aplastic anemia Market by Treatment type, Performance - Potential Analysis
  • 5.3. Global Aplastic anemia Market Estimates & Forecasts by Treatment type 2017-2027 (USD Billion)
  • 5.4. Aplastic anemia Market, Sub Segment Analysis
    • 5.4.1. Bone Marrow Transfusion/Stem Cell Therapy
    • 5.4.2. Blood Transfusion
    • 5.4.3. Drug Therapy

Chapter 6. Global Aplastic anemia Market, by Disease type

  • 6.1. Market Snapshot
  • 6.2. Global Aplastic anemia Market by Disease type, Performance - Potential Analysis
  • 6.3. Global Aplastic anemia Market Estimates & Forecasts by Disease type 2017-2027 (USD Billion)
  • 6.4. Aplastic anemia Market, Sub Segment Analysis
    • 6.4.1. Acquired Aplastic Anemia
    • 6.4.2. Inherited Bone Marrow Failure Syndromes

Chapter 7. Global Aplastic anemia Market, by Route of administration

  • 7.1. Market Snapshot
  • 7.2. Global Aplastic anemia Market by Route of administration, Performance - Potential Analysis
  • 7.3. Global Aplastic anemia Market Estimates & Forecasts by Route of administration 2017-2027 (USD Billion)
  • 7.4. Aplastic anemia Market, Sub Segment Analysis
    • 7.4.1. Intravenous
    • 7.4.2. Oral

Chapter 8. Global Aplastic anemia Market, by Distribution channel

  • 8.1. Market Snapshot
  • 8.2. Global Aplastic anemia Market by Distribution channel, Performance - Potential Analysis
  • 8.3. Global Aplastic anemia Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)
  • 8.4. Aplastic anemia Market, Sub Segment Analysis
    • 8.4.1. Retail Pharmacies
    • 8.4.2. Hospital Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Aplastic anemia Market, Regional Analysis

  • 9.1. Aplastic anemia Market, Regional Market Snapshot
  • 9.2. North America Aplastic anemia Market
    • 9.2.1. U.S. Aplastic anemia Market
      • 9.2.1.1. Treatment type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Diseases type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Route of administration breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. Distribution channel breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Aplastic anemia Market
  • 9.3. Europe Aplastic anemia Market Snapshot
    • 9.3.1. U.K. Aplastic anemia Market
    • 9.3.2. Germany Aplastic anemia Market
    • 9.3.3. France Aplastic anemia Market
    • 9.3.4. Spain Aplastic anemia Market
    • 9.3.5. Italy Aplastic anemia Market
    • 9.3.6. Rest of Europe Aplastic anemia Market
  • 9.4. Asia-Pacific Aplastic anemia Market Snapshot
    • 9.4.1. China Aplastic anemia Market
    • 9.4.2. India Aplastic anemia Market
    • 9.4.3. Japan Aplastic anemia Market
    • 9.4.4. Australia Aplastic anemia Market
    • 9.4.5. South Korea Aplastic anemia Market
    • 9.4.6. Rest of Asia Pacific Aplastic anemia Market
  • 9.5. Latin America Aplastic anemia Market Snapshot
    • 9.5.1. Brazil Aplastic anemia Market
    • 9.5.2. Mexico Aplastic anemia Market
  • 9.6. Rest of The World Aplastic anemia Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Bayer AG
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. Pfizer Inc.
    • 10.2.4. Ligand Pharmaceuticals Incorporated
    • 10.2.5. Genzyme Corporation
    • 10.2.6. Mylan N.V.
    • 10.2.7. Biogen
    • 10.2.8. Otsuka Pharmaceutical Co. Ltd.
    • 10.2.9. Regen BioPharma Inc.
    • 10.2.10. BioLineRx

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Aplastic anemia market, report scope
  • TABLE 2. Global Aplastic anemia market estimates & forecasts by Region 2017-2027 (USD Billion)
  • TABLE 3. Global Aplastic anemia market estimates & forecasts by Treatment type 2017-2027 (USD Billion)
  • TABLE 4. Global Aplastic anemia market estimates & forecasts by Diseases type 2017-2027 (USD Billion)
  • TABLE 5. Global Aplastic anemia market estimates & forecasts by Route of administration 2017-2027 (USD Billion)
  • TABLE 6. Global Aplastic anemia market estimates & forecasts by Distribution channel 2017-2027 (USD Billion)
  • TABLE 7. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. U.S. Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. U.S. Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 19. U.S. Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 20. Canada Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Canada Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 22. Canada Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 23. UK Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 24. UK Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 25. UK Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 26. Germany Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 27. Germany Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 28. Germany Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 29. RoE Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 30. RoE Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. RoE Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. China Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 33. China Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. China Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. India Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 36. India Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 37. India Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. Japan Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 39. Japan Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. Japan Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 41. RoAPAC Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 42. RoAPAC Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. RoAPAC Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. Brazil Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 45. Brazil Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. Brazil Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. Mexico Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 48. Mexico Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. Mexico Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. RoLA Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 51. RoLA Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. RoLA Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. Row Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 54. Row Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. Row Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Aplastic anemia market
  • TABLE 57. List of primary sources, used in the study of global Aplastic anemia market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Aplastic anemia market, research methodology
  • FIG 2. Global Aplastic anemia market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Aplastic anemia market, key trends 2019
  • FIG 5. Global Aplastic anemia market, growth prospects 2020-2027
  • FIG 6. Global Aplastic anemia market, porters 5 force model
  • FIG 7. Global Aplastic anemia market, pest analysis
  • FIG 8. Global Aplastic anemia market, value chain analysis
  • FIG 9. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Aplastic anemia market, regional snapshot 2017 & 2027
  • FIG 15. North America Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 16. Europe Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 17. Asia pacific Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 18. Latin America Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 19. Global Aplastic anemia market, company market share analysis (2019)